| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | Notch binding | 3.34e-06 | 27 | 22 | 3 | GO:0005112 | |
| GeneOntologyMolecularFunction | opsonin binding | 3.42e-04 | 25 | 22 | 2 | GO:0001846 | |
| GeneOntologyMolecularFunction | complement binding | 5.63e-04 | 32 | 22 | 2 | GO:0001848 | |
| GeneOntologyBiologicalProcess | eye morphogenesis | 2.07e-06 | 204 | 22 | 5 | GO:0048592 | |
| GeneOntologyBiologicalProcess | eye development | 8.37e-06 | 480 | 22 | 6 | GO:0001654 | |
| GeneOntologyBiologicalProcess | visual system development | 8.67e-06 | 483 | 22 | 6 | GO:0150063 | |
| GeneOntologyBiologicalProcess | sensory system development | 9.52e-06 | 491 | 22 | 6 | GO:0048880 | |
| GeneOntologyBiologicalProcess | inhibition of neuroepithelial cell differentiation | 1.62e-05 | 6 | 22 | 2 | GO:0002085 | |
| GeneOntologyBiologicalProcess | recognition of apoptotic cell | 2.27e-05 | 7 | 22 | 2 | GO:0043654 | |
| GeneOntologyBiologicalProcess | sensory organ morphogenesis | 2.58e-05 | 343 | 22 | 5 | GO:0090596 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | 2.95e-05 | 1269 | 22 | 8 | GO:0009887 | |
| GeneOntologyBiologicalProcess | camera-type eye morphogenesis | 2.97e-05 | 171 | 22 | 4 | GO:0048593 | |
| GeneOntologyBiologicalProcess | positive regulation of cardiac epithelial to mesenchymal transition | 3.89e-05 | 9 | 22 | 2 | GO:0062043 | |
| GeneOntologyBiologicalProcess | inner ear auditory receptor cell differentiation | 4.83e-05 | 67 | 22 | 3 | GO:0042491 | |
| GeneOntologyBiologicalProcess | distal tubule development | 4.86e-05 | 10 | 22 | 2 | GO:0072017 | |
| GeneOntologyBiologicalProcess | eye photoreceptor cell differentiation | 5.99e-05 | 72 | 22 | 3 | GO:0001754 | |
| GeneOntologyBiologicalProcess | camera-type eye development | 7.23e-05 | 426 | 22 | 5 | GO:0043010 | |
| GeneOntologyBiologicalProcess | glomerulus development | 7.32e-05 | 77 | 22 | 3 | GO:0032835 | |
| GeneOntologyBiologicalProcess | hair cell differentiation | 7.61e-05 | 78 | 22 | 3 | GO:0035315 | |
| GeneOntologyBiologicalProcess | sensory organ development | 8.84e-05 | 730 | 22 | 6 | GO:0007423 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | 8.86e-05 | 1077 | 22 | 7 | GO:0098609 | |
| GeneOntologyBiologicalProcess | regulation of cardiac epithelial to mesenchymal transition | 9.81e-05 | 14 | 22 | 2 | GO:0062042 | |
| GeneOntologyBiologicalProcess | regulation of timing of cell differentiation | 1.13e-04 | 15 | 22 | 2 | GO:0048505 | |
| GeneOntologyBiologicalProcess | neuroendocrine cell differentiation | 1.29e-04 | 16 | 22 | 2 | GO:0061101 | |
| GeneOntologyBiologicalProcess | inner ear receptor cell differentiation | 1.41e-04 | 96 | 22 | 3 | GO:0060113 | |
| GeneOntologyBiologicalProcess | photoreceptor cell differentiation | 1.41e-04 | 96 | 22 | 3 | GO:0046530 | |
| GeneOntologyBiologicalProcess | regulation of development, heterochronic | 1.46e-04 | 17 | 22 | 2 | GO:0040034 | |
| GeneOntologyBiologicalProcess | regulation of embryonic development | 1.55e-04 | 99 | 22 | 3 | GO:0045995 | |
| GeneOntologyBiologicalProcess | mechanoreceptor differentiation | 1.79e-04 | 104 | 22 | 3 | GO:0042490 | |
| GeneOntologyBiologicalProcess | muscle cell differentiation | 2.03e-04 | 531 | 22 | 5 | GO:0042692 | |
| GeneOntologyBiologicalProcess | pulmonary valve morphogenesis | 2.04e-04 | 20 | 22 | 2 | GO:0003184 | |
| GeneOntologyBiologicalProcess | muscle structure development | 2.14e-04 | 858 | 22 | 6 | GO:0061061 | |
| GeneOntologyBiologicalProcess | ear development | 2.15e-04 | 285 | 22 | 4 | GO:0043583 | |
| GeneOntologyBiologicalProcess | response to muramyl dipeptide | 2.25e-04 | 21 | 22 | 2 | GO:0032495 | |
| GeneOntologyBiologicalProcess | cardiac right ventricle morphogenesis | 2.25e-04 | 21 | 22 | 2 | GO:0003215 | |
| GeneOntologyBiologicalProcess | pulmonary valve development | 2.96e-04 | 24 | 22 | 2 | GO:0003177 | |
| GeneOntologyBiologicalProcess | establishment of pigment granule localization | 2.96e-04 | 24 | 22 | 2 | GO:0051905 | |
| GeneOntologyBiologicalProcess | homotypic cell-cell adhesion | 3.00e-04 | 124 | 22 | 3 | GO:0034109 | |
| GeneOntologyBiologicalProcess | pigment granule localization | 3.48e-04 | 26 | 22 | 2 | GO:0051875 | |
| GeneOntologyBiologicalProcess | myoblast differentiation | 3.94e-04 | 136 | 22 | 3 | GO:0045445 | |
| GeneOntologyBiologicalProcess | negative regulation of stem cell differentiation | 5.62e-04 | 33 | 22 | 2 | GO:2000737 | |
| GeneOntologyBiologicalProcess | aortic valve morphogenesis | 7.86e-04 | 39 | 22 | 2 | GO:0003180 | |
| GeneOntologyBiologicalProcess | nephron development | 8.08e-04 | 174 | 22 | 3 | GO:0072006 | |
| GeneOntologyBiologicalProcess | cardiac epithelial to mesenchymal transition | 8.27e-04 | 40 | 22 | 2 | GO:0060317 | |
| GeneOntologyBiologicalProcess | aorta morphogenesis | 8.68e-04 | 41 | 22 | 2 | GO:0035909 | |
| GeneOntologyBiologicalProcess | phagocytosis, recognition | 9.11e-04 | 42 | 22 | 2 | GO:0006910 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | 9.75e-04 | 748 | 22 | 5 | GO:0048667 | |
| GeneOntologyBiologicalProcess | muscle organ development | 1.06e-03 | 436 | 22 | 4 | GO:0007517 | |
| GeneOntologyBiologicalProcess | aortic valve development | 1.09e-03 | 46 | 22 | 2 | GO:0003176 | |
| GeneOntologyBiologicalProcess | apoptotic process involved in development | 1.14e-03 | 47 | 22 | 2 | GO:1902742 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation involved in kidney development | 1.14e-03 | 47 | 22 | 2 | GO:0035850 | |
| GeneOntologyBiologicalProcess | apoptotic cell clearance | 1.19e-03 | 48 | 22 | 2 | GO:0043277 | |
| GeneOntologyBiologicalProcess | regulation of muscle cell differentiation | 1.19e-03 | 199 | 22 | 3 | GO:0051147 | |
| GeneOntologyBiologicalProcess | camera-type eye photoreceptor cell differentiation | 1.24e-03 | 49 | 22 | 2 | GO:0060219 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | 1.24e-03 | 1194 | 22 | 6 | GO:0000902 | |
| GeneOntologyBiologicalProcess | semi-lunar valve development | 1.29e-03 | 50 | 22 | 2 | GO:1905314 | |
| GeneOntologyBiologicalProcess | response to lipopolysaccharide | 1.34e-03 | 464 | 22 | 4 | GO:0032496 | |
| GeneOntologyBiologicalProcess | neuroepithelial cell differentiation | 1.34e-03 | 51 | 22 | 2 | GO:0060563 | |
| GeneOntologyBiologicalProcess | eye photoreceptor cell development | 1.39e-03 | 52 | 22 | 2 | GO:0042462 | |
| GeneOntologyBiologicalProcess | positive regulation of Notch signaling pathway | 1.45e-03 | 53 | 22 | 2 | GO:0045747 | |
| GeneOntologyBiologicalProcess | negative regulation of chemotaxis | 1.50e-03 | 54 | 22 | 2 | GO:0050922 | |
| GeneOntologyBiologicalProcess | vascular associated smooth muscle cell differentiation | 1.56e-03 | 55 | 22 | 2 | GO:0035886 | |
| GeneOntologyBiologicalProcess | skeletal muscle tissue development | 1.65e-03 | 223 | 22 | 3 | GO:0007519 | |
| GeneOntologyBiologicalProcess | response to molecule of bacterial origin | 1.65e-03 | 491 | 22 | 4 | GO:0002237 | |
| GeneOntologyBiologicalProcess | cell differentiation involved in kidney development | 1.67e-03 | 57 | 22 | 2 | GO:0061005 | |
| GeneOntologyBiologicalProcess | endocardial cushion development | 1.73e-03 | 58 | 22 | 2 | GO:0003197 | |
| GeneOntologyBiologicalProcess | skeletal muscle organ development | 2.03e-03 | 240 | 22 | 3 | GO:0060538 | |
| GeneOntologyBiologicalProcess | heart valve morphogenesis | 2.04e-03 | 63 | 22 | 2 | GO:0003179 | |
| GeneOntologyBiologicalProcess | positive regulation of epithelial to mesenchymal transition | 2.04e-03 | 63 | 22 | 2 | GO:0010718 | |
| GeneOntologyBiologicalProcess | cellular pigmentation | 2.10e-03 | 64 | 22 | 2 | GO:0033059 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell differentiation | 2.30e-03 | 67 | 22 | 2 | GO:0045601 | |
| GeneOntologyBiologicalProcess | inner ear development | 2.36e-03 | 253 | 22 | 3 | GO:0048839 | |
| GeneOntologyBiologicalProcess | negative regulation of epithelial cell differentiation | 2.44e-03 | 69 | 22 | 2 | GO:0030857 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | 2.52e-03 | 927 | 22 | 5 | GO:0030155 | |
| GeneOntologyBiologicalProcess | muscle cell development | 2.53e-03 | 259 | 22 | 3 | GO:0055001 | |
| GeneOntologyBiologicalProcess | response to tumor cell | 2.58e-03 | 71 | 22 | 2 | GO:0002347 | |
| GeneOntologyBiologicalProcess | photoreceptor cell development | 2.73e-03 | 73 | 22 | 2 | GO:0042461 | |
| GeneOntologyBiologicalProcess | axonogenesis | 2.77e-03 | 566 | 22 | 4 | GO:0007409 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelial sheet | 2.80e-03 | 74 | 22 | 2 | GO:0002011 | |
| GeneOntologyBiologicalProcess | negative regulation of cell-substrate adhesion | 2.80e-03 | 74 | 22 | 2 | GO:0010812 | |
| GeneOntologyBiologicalProcess | phagocytosis | 2.96e-03 | 274 | 22 | 3 | GO:0006909 | |
| GeneOntologyBiologicalProcess | regulation of cell-cell adhesion | 3.02e-03 | 580 | 22 | 4 | GO:0022407 | |
| GeneOntologyBiologicalProcess | heart valve development | 3.11e-03 | 78 | 22 | 2 | GO:0003170 | |
| GeneOntologyCellularComponent | apical plasma membrane | 1.28e-04 | 487 | 22 | 5 | GO:0016324 | |
| GeneOntologyCellularComponent | apical part of cell | 3.16e-04 | 592 | 22 | 5 | GO:0045177 | |
| GeneOntologyCellularComponent | phagocytic cup | 4.83e-04 | 31 | 22 | 2 | GO:0001891 | |
| GeneOntologyCellularComponent | extracellular matrix | 5.06e-04 | 656 | 22 | 5 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 5.13e-04 | 658 | 22 | 5 | GO:0030312 | |
| GeneOntologyCellularComponent | adherens junction | 1.37e-03 | 212 | 22 | 3 | GO:0005912 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 2.08e-03 | 530 | 22 | 4 | GO:0062023 | |
| MousePheno | abnormal cochlear hair cell number | 1.49e-06 | 68 | 18 | 4 | MP:0004406 | |
| MousePheno | abnormal sensory neuron morphology | 1.91e-05 | 473 | 18 | 6 | MP:0000965 | |
| MousePheno | abnormal vestibular hair cell morphology | 2.99e-05 | 48 | 18 | 3 | MP:0002623 | |
| MousePheno | abnormal inner ear morphology | 3.15e-05 | 303 | 18 | 5 | MP:0000026 | |
| MousePheno | abnormal cochlear outer hair cell number | 3.38e-05 | 50 | 18 | 3 | MP:0004400 | |
| MousePheno | decreased cochlear hair cell number | 4.03e-05 | 53 | 18 | 3 | MP:0004408 | |
| MousePheno | absent vestibular hair cells | 4.36e-05 | 8 | 18 | 2 | MP:0004325 | |
| MousePheno | abnormal cochlear hair cell morphology | 1.10e-04 | 202 | 18 | 4 | MP:0002622 | |
| MousePheno | abnormal cochlear sensory epithelium morphology | 1.21e-04 | 207 | 18 | 4 | MP:0003308 | |
| MousePheno | abnormal organ of Corti morphology | 1.26e-04 | 209 | 18 | 4 | MP:0000042 | |
| MousePheno | stereotypic behavior | 1.38e-04 | 214 | 18 | 4 | MP:0001408 | |
| MousePheno | abnormal hair cell morphology | 1.38e-04 | 214 | 18 | 4 | MP:0000045 | |
| MousePheno | stria vascularis degeneration | 1.41e-04 | 14 | 18 | 2 | MP:0004363 | |
| MousePheno | abnormal inner ear vestibule morphology | 1.44e-04 | 81 | 18 | 3 | MP:0000034 | |
| MousePheno | abnormal somatic nervous system morphology | 1.73e-04 | 1025 | 18 | 7 | MP:0002752 | |
| MousePheno | abnormal somatic sensory system morphology | 1.73e-04 | 702 | 18 | 6 | MP:0000959 | |
| MousePheno | abnormal mechanoreceptor morphology | 1.85e-04 | 231 | 18 | 4 | MP:0000972 | |
| MousePheno | decreased vestibular hair cell number | 1.86e-04 | 16 | 18 | 2 | MP:0004328 | |
| MousePheno | abnormal cochlear labyrinth morphology | 1.98e-04 | 235 | 18 | 4 | MP:0004426 | |
| MousePheno | abnormal scala media morphology | 1.98e-04 | 235 | 18 | 4 | MP:0003169 | |
| MousePheno | abnormal cochlea morphology | 2.43e-04 | 248 | 18 | 4 | MP:0000031 | |
| MousePheno | abnormal ear morphology | 2.51e-04 | 470 | 18 | 5 | MP:0002102 | |
| MousePheno | abnormal vestibular hair cell number | 2.64e-04 | 19 | 18 | 2 | MP:0004326 | |
| MousePheno | increased cochlear hair cell number | 2.93e-04 | 20 | 18 | 2 | MP:0004407 | |
| MousePheno | abnormal membranous labyrinth morphology | 3.00e-04 | 262 | 18 | 4 | MP:0000035 | |
| MousePheno | head shaking | 3.56e-04 | 22 | 18 | 2 | MP:0002730 | |
| MousePheno | circling | 4.25e-04 | 117 | 18 | 3 | MP:0001394 | |
| MousePheno | increased hemangioma incidence | 7.59e-04 | 32 | 18 | 2 | MP:0002947 | |
| MousePheno | head tossing | 9.09e-04 | 35 | 18 | 2 | MP:0005307 | |
| MousePheno | decreased cochlear outer hair cell number | 9.09e-04 | 35 | 18 | 2 | MP:0004402 | |
| MousePheno | craniofacial phenotype | 1.04e-03 | 1372 | 18 | 7 | MP:0005382 | |
| MousePheno | abnormal craniofacial morphology | 1.04e-03 | 1372 | 18 | 7 | MP:0000428 | |
| MousePheno | abnormal cochlear outer hair cell morphology | 1.04e-03 | 159 | 18 | 3 | MP:0004399 | |
| MousePheno | abnormal basement membrane morphology | 1.19e-03 | 40 | 18 | 2 | MP:0004272 | |
| MousePheno | increased sensory neuron number | 1.25e-03 | 41 | 18 | 2 | MP:0006006 | |
| MousePheno | internal hemorrhage | 1.30e-03 | 387 | 18 | 4 | MP:0001634 | |
| MousePheno | increased variability of skeletal muscle fiber size | 1.37e-03 | 43 | 18 | 2 | MP:0009403 | |
| MousePheno | abnormal stria vascularis morphology | 1.43e-03 | 44 | 18 | 2 | MP:0000048 | |
| MousePheno | abnormal axial skeleton morphology | 1.49e-03 | 1458 | 18 | 7 | MP:0002114 | |
| MousePheno | abnormal enamel morphology | 1.50e-03 | 45 | 18 | 2 | MP:0002576 | |
| MousePheno | decreased sensory neuron number | 1.51e-03 | 181 | 18 | 3 | MP:0000966 | |
| MousePheno | head bobbing | 1.92e-03 | 51 | 18 | 2 | MP:0001410 | |
| MousePheno | abnormal molar morphology | 1.92e-03 | 51 | 18 | 2 | MP:0002689 | |
| MousePheno | abnormal muscle morphology | 1.96e-03 | 1106 | 18 | 6 | MP:0002108 | |
| MousePheno | abnormal otolith organ morphology | 2.23e-03 | 55 | 18 | 2 | MP:0004425 | |
| MousePheno | distended pericardium | 2.23e-03 | 55 | 18 | 2 | MP:0000292 | |
| MousePheno | abnormal neuron number | 2.38e-03 | 456 | 18 | 4 | MP:0008946 | |
| MousePheno | kinked neural tube | 2.40e-03 | 57 | 18 | 2 | MP:0003400 | |
| MousePheno | cochlear degeneration | 2.83e-03 | 62 | 18 | 2 | MP:0000032 | |
| MousePheno | abnormal tooth hard tissue morphology | 2.92e-03 | 63 | 18 | 2 | MP:0003930 | |
| MousePheno | abnormal cranium morphology | 2.98e-03 | 813 | 18 | 5 | MP:0000438 | |
| MousePheno | abnormal craniofacial bone morphology | 3.21e-03 | 827 | 18 | 5 | MP:0002116 | |
| MousePheno | decreased a-wave amplitude | 3.30e-03 | 67 | 18 | 2 | MP:0012143 | |
| MousePheno | abnormal blood coagulation | 3.37e-03 | 240 | 18 | 3 | MP:0002551 | |
| MousePheno | abnormal hemostasis | 3.45e-03 | 242 | 18 | 3 | MP:0009676 | |
| MousePheno | abnormal a-wave amplitude | 3.49e-03 | 69 | 18 | 2 | MP:0012030 | |
| MousePheno | abnormal a-wave shape | 3.59e-03 | 70 | 18 | 2 | MP:0012034 | |
| MousePheno | increased neuron number | 3.79e-03 | 72 | 18 | 2 | MP:0008947 | |
| Domain | EGF | 2.93e-12 | 235 | 22 | 9 | SM00181 | |
| Domain | EGF-like_dom | 4.92e-12 | 249 | 22 | 9 | IPR000742 | |
| Domain | EGF_1 | 6.10e-12 | 255 | 22 | 9 | PS00022 | |
| Domain | EGF-like_CS | 7.52e-12 | 261 | 22 | 9 | IPR013032 | |
| Domain | EGF_2 | 8.62e-12 | 265 | 22 | 9 | PS01186 | |
| Domain | hEGF | 1.34e-10 | 28 | 22 | 5 | PF12661 | |
| Domain | EGF_3 | 1.53e-10 | 235 | 22 | 8 | PS50026 | |
| Domain | Laminin_EGF | 4.41e-10 | 35 | 22 | 5 | PF00053 | |
| Domain | EGF_Lam | 4.41e-10 | 35 | 22 | 5 | SM00180 | |
| Domain | Laminin_EGF | 6.81e-10 | 38 | 22 | 5 | IPR002049 | |
| Domain | EGF_extracell | 6.74e-07 | 60 | 22 | 4 | IPR013111 | |
| Domain | EGF_2 | 6.74e-07 | 60 | 22 | 4 | PF07974 | |
| Domain | EMI_domain | 7.86e-07 | 16 | 22 | 3 | IPR011489 | |
| Domain | EMI | 9.54e-07 | 17 | 22 | 3 | PS51041 | |
| Domain | EGF_CA | 2.88e-06 | 86 | 22 | 4 | PF07645 | |
| Domain | EGF_Ca-bd_CS | 4.65e-06 | 97 | 22 | 4 | IPR018097 | |
| Domain | EGF_CA | 5.05e-06 | 99 | 22 | 4 | PS01187 | |
| Domain | ASX_HYDROXYL | 5.26e-06 | 100 | 22 | 4 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 6.63e-06 | 106 | 22 | 4 | IPR000152 | |
| Domain | EGF_CA | 1.16e-05 | 122 | 22 | 4 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.23e-05 | 124 | 22 | 4 | IPR001881 | |
| Domain | EGF | 1.31e-05 | 126 | 22 | 4 | PF00008 | |
| Domain | Growth_fac_rcpt_ | 3.05e-05 | 156 | 22 | 4 | IPR009030 | |
| Domain | LAMININ_NTER | 1.57e-04 | 16 | 22 | 2 | PS51117 | |
| Domain | Laminin_N | 1.57e-04 | 16 | 22 | 2 | PF00055 | |
| Domain | Laminin_N | 1.57e-04 | 16 | 22 | 2 | IPR008211 | |
| Domain | LamNT | 1.57e-04 | 16 | 22 | 2 | SM00136 | |
| Domain | EGF_LAM_2 | 5.65e-04 | 30 | 22 | 2 | PS50027 | |
| Domain | EGF_LAM_1 | 5.65e-04 | 30 | 22 | 2 | PS01248 | |
| Domain | Ank_2 | 1.97e-03 | 215 | 22 | 3 | PF12796 | |
| Domain | Ank | 2.33e-03 | 228 | 22 | 3 | PF00023 | |
| Domain | - | 2.96e-03 | 248 | 22 | 3 | 1.25.40.20 | |
| Domain | ANK | 3.06e-03 | 251 | 22 | 3 | SM00248 | |
| Domain | ANK_REPEAT | 3.13e-03 | 253 | 22 | 3 | PS50088 | |
| Domain | Ankyrin_rpt-contain_dom | 3.16e-03 | 254 | 22 | 3 | IPR020683 | |
| Domain | ANK_REP_REGION | 3.16e-03 | 254 | 22 | 3 | PS50297 | |
| Domain | - | 3.31e-03 | 73 | 22 | 2 | 2.60.120.260 | |
| Domain | Ankyrin_rpt | 3.45e-03 | 262 | 22 | 3 | IPR002110 | |
| Domain | Galactose-bd-like | 5.42e-03 | 94 | 22 | 2 | IPR008979 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT | 2.53e-05 | 7 | 16 | 2 | M27199 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 7.92e-05 | 12 | 16 | 2 | M47532 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 9.35e-05 | 13 | 16 | 2 | M47423 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 1.09e-04 | 14 | 16 | 2 | M27808 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER | 1.26e-04 | 15 | 16 | 2 | M27202 | |
| Pathway | KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY | 1.44e-04 | 16 | 16 | 2 | M47424 | |
| Pathway | WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS | 1.63e-04 | 17 | 16 | 2 | M39443 | |
| Pathway | WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION | 1.63e-04 | 17 | 16 | 2 | M39389 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 4.17e-04 | 27 | 16 | 2 | M39545 | |
| Pathway | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | 5.51e-04 | 31 | 16 | 2 | M592 | |
| Pathway | WP_NEOVASCULARIZATION_PROCESSES | 7.86e-04 | 37 | 16 | 2 | M39506 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 8.73e-04 | 39 | 16 | 2 | MM14604 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 1.16e-03 | 45 | 16 | 2 | M39571 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 1.21e-03 | 46 | 16 | 2 | MM15971 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 1.27e-03 | 47 | 16 | 2 | M7946 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 1.38e-03 | 49 | 16 | 2 | M618 | |
| Pathway | WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM | 1.86e-03 | 57 | 16 | 2 | M48326 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER | 1.92e-03 | 58 | 16 | 2 | M29616 | |
| Pathway | WP_MARKERS_OF_KIDNEY_CELL_LINEAGE | 1.99e-03 | 59 | 16 | 2 | M46460 | |
| Pathway | PID_NOTCH_PATHWAY | 1.99e-03 | 59 | 16 | 2 | M17 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 2.13e-03 | 61 | 16 | 2 | M39540 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 2.63e-03 | 68 | 16 | 2 | M27303 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 2.95e-03 | 72 | 16 | 2 | M39403 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 3.03e-03 | 73 | 16 | 2 | MM15906 | |
| Pathway | WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY | 3.11e-03 | 74 | 16 | 2 | M39462 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 3.11e-03 | 74 | 16 | 2 | M616 | |
| Pathway | KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC | 3.11e-03 | 74 | 16 | 2 | M16376 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH4 | 3.80e-03 | 82 | 16 | 2 | M594 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 3.80e-03 | 82 | 16 | 2 | MM15922 | |
| Pathway | KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM | 3.90e-03 | 83 | 16 | 2 | M8728 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 4.35e-03 | 300 | 16 | 3 | M610 | |
| Pathway | KEGG_DILATED_CARDIOMYOPATHY | 4.56e-03 | 90 | 16 | 2 | M835 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3 | 5.18e-03 | 96 | 16 | 2 | M27784 | |
| Pubmed | Pax2 and Pax8 cooperate in mouse inner ear morphogenesis and innervation. | 1.84e-08 | 9 | 22 | 3 | 20727173 | |
| Pubmed | 9.95e-08 | 15 | 22 | 3 | 27966429 | ||
| Pubmed | COUP-TFI controls Notch regulation of hair cell and support cell differentiation. | 9.95e-08 | 15 | 22 | 3 | 16914494 | |
| Pubmed | Lrrn1 Regulates Medial Boundary Formation in the Developing Mouse Organ of Corti. | 2.49e-07 | 20 | 22 | 3 | 37369584 | |
| Pubmed | Up-regulated expression of Notch1 and Jagged1 in human colon adenocarcinoma. | 3.82e-07 | 2 | 22 | 2 | 21145176 | |
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 29708032 | ||
| Pubmed | The Notch ligand Jagged-1 is able to induce maturation of monocyte-derived human dendritic cells. | 3.82e-07 | 2 | 22 | 2 | 12370358 | |
| Pubmed | Blocking the NOTCH pathway inhibits vascular inflammation in large-vessel vasculitis. | 3.82e-07 | 2 | 22 | 2 | 21220737 | |
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 27216293 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 12357247 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 11964309 | ||
| Pubmed | Molecular basis for Jagged-1/Serrate ligand recognition by the Notch receptor. | 3.82e-07 | 2 | 22 | 2 | 23339193 | |
| Pubmed | A mutation in EGF repeat-8 of Notch discriminates between Serrate/Jagged and Delta family ligands. | 3.82e-07 | 2 | 22 | 2 | 23197537 | |
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 29242532 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 25380486 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 21156172 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 18593716 | ||
| Pubmed | Suppression of renal cell carcinoma growth by inhibition of Notch signaling in vitro and in vivo. | 3.82e-07 | 2 | 22 | 2 | 18079963 | |
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 26921446 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 18192230 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 38783634 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 18660822 | ||
| Pubmed | Spatially restricted JAG1-Notch signaling in human thymus provides suitable DC developmental niches. | 3.82e-07 | 2 | 22 | 2 | 28947612 | |
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 25842263 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 30943513 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 22348356 | ||
| Pubmed | Epidermal stem cells (ESCs) accelerate diabetic wound healing via the Notch signalling pathway. | 3.82e-07 | 2 | 22 | 2 | 27129289 | |
| Pubmed | Jagged1 and Notch1 help edit M cell patterning in Peyer's patch follicle epithelium. | 3.82e-07 | 2 | 22 | 2 | 22504165 | |
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 20800871 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 25903338 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 26646450 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 15550486 | ||
| Pubmed | [Gene expression of Notch1 and Jagged1 in children with acute leukemia]. | 3.82e-07 | 2 | 22 | 2 | 22357466 | |
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 30231940 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 20517681 | ||
| Pubmed | A study of the role of Notch1 and JAG1 gene methylation in development of breast cancer. | 3.82e-07 | 2 | 22 | 2 | 26971121 | |
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 26507745 | ||
| Pubmed | Jagged1 signals in the postnatal subventricular zone are required for neural stem cell self-renewal. | 3.82e-07 | 2 | 22 | 2 | 16163386 | |
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 18292500 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 26249804 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 21712044 | ||
| Pubmed | Immunohistochemical localization of Notch signaling molecules in ameloblastomas. | 3.82e-07 | 2 | 22 | 2 | 21810559 | |
| Pubmed | Rbpj regulates development of prosensory cells in the mammalian inner ear. | 4.41e-07 | 24 | 22 | 3 | 21420948 | |
| Pubmed | Continued expression of GATA3 is necessary for cochlear neurosensory development. | 4.41e-07 | 24 | 22 | 3 | 23614009 | |
| Pubmed | GATA3 controls the specification of prosensory domain and neuronal survival in the mouse cochlea. | 6.36e-07 | 27 | 22 | 3 | 23666531 | |
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 16867989 | ||
| Pubmed | Activation of Notch signal pathway is associated with a poorer prognosis in acute myeloid leukemia. | 1.15e-06 | 3 | 22 | 2 | 20812035 | |
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 24659709 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 26341090 | ||
| Pubmed | Consequences of MEGF10 deficiency on myoblast function and Notch1 interactions. | 1.15e-06 | 3 | 22 | 2 | 28498977 | |
| Pubmed | Both Notch1 and its ligands in B cells promote antibody production. | 1.15e-06 | 3 | 22 | 2 | 28863329 | |
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 19728763 | ||
| Pubmed | Notch1, Jagged1, and HES5 are abundantly expressed in osteoarthritis. | 1.15e-06 | 3 | 22 | 2 | 18354251 | |
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 22753939 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 22080880 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 27612417 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 26191142 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 14988227 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 26406415 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 15939383 | ||
| Pubmed | Inhibition of HER2 Increases JAGGED1-dependent Breast Cancer Stem Cells: Role for Membrane JAGGED1. | 1.15e-06 | 3 | 22 | 2 | 29895705 | |
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 25176314 | ||
| Pubmed | Jagged1 is necessary for postnatal and adult neurogenesis in the dentate gyrus. | 1.15e-06 | 3 | 22 | 2 | 24530424 | |
| Pubmed | Astrocyte-derived Jagged-1 mitigates deleterious Notch signaling in amyotrophic lateral sclerosis. | 1.15e-06 | 3 | 22 | 2 | 30010003 | |
| Pubmed | Notch signaling represses myocardin-induced smooth muscle cell differentiation. | 1.15e-06 | 3 | 22 | 2 | 15634680 | |
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 15280477 | ||
| Pubmed | Olfactory Sensory Neurons Control Dendritic Complexity of Mitral Cells via Notch Signaling. | 1.15e-06 | 3 | 22 | 2 | 28027303 | |
| Pubmed | Notch pathway activation enhances cardiosphere in vitro expansion. | 1.15e-06 | 3 | 22 | 2 | 30138533 | |
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 20154142 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 34519870 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 15781650 | ||
| Pubmed | Jagged1-induced Notch signaling drives proliferation of multiple myeloma cells. | 1.15e-06 | 3 | 22 | 2 | 14726396 | |
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 33046710 | ||
| Pubmed | Intracellular pathogen sensor NOD2 programs macrophages to trigger Notch1 activation. | 1.15e-06 | 3 | 22 | 2 | 21156799 | |
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 20940224 | ||
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 31781973 | ||
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 10837254 | ||
| Pubmed | Differential regulation of osteoclastogenesis by Notch2/Delta-like 1 and Notch1/Jagged1 axes. | 2.29e-06 | 4 | 22 | 2 | 22390640 | |
| Pubmed | Jagged1/Notch2 controls kidney fibrosis via Tfam-mediated metabolic reprogramming. | 2.29e-06 | 4 | 22 | 2 | 30226866 | |
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 10551863 | ||
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 9315665 | ||
| Pubmed | No evidence for a functional role of bi-directional Notch signaling during angiogenesis. | 2.29e-06 | 4 | 22 | 2 | 23300864 | |
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 17984306 | ||
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 20819128 | ||
| Pubmed | A tail of two sites: a bipartite mechanism for recognition of notch ligands by mind bomb E3 ligases. | 2.29e-06 | 4 | 22 | 2 | 25747658 | |
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 36376768 | ||
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 22020917 | ||
| Pubmed | Jedi-1 and MEGF10 signal engulfment of apoptotic neurons through the tyrosine kinase Syk. | 2.29e-06 | 4 | 22 | 2 | 22993420 | |
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 29199954 | ||
| Pubmed | Detection of Notch signaling molecules in cemento-ossifying fibroma of the jaws. | 2.29e-06 | 4 | 22 | 2 | 20040020 | |
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 9858728 | ||
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 24398584 | ||
| Pubmed | 3.82e-06 | 5 | 22 | 2 | 20870935 | ||
| Pubmed | Physical interaction of Delta1, Jagged1, and Jagged2 with Notch1 and Notch3 receptors. | 3.82e-06 | 5 | 22 | 2 | 11006133 | |
| Pubmed | Jagged1 is the major regulator of Notch-dependent cell fate in proximal airways. | 3.82e-06 | 5 | 22 | 2 | 23526493 | |
| Pubmed | 3.82e-06 | 5 | 22 | 2 | 21820430 | ||
| Pubmed | Functional diversity of notch family genes in fetal lung development. | 3.82e-06 | 5 | 22 | 2 | 15064243 | |
| Pubmed | 3.82e-06 | 5 | 22 | 2 | 16736472 | ||
| Pubmed | 3.82e-06 | 5 | 22 | 2 | 11713346 | ||
| Pubmed | Control of Notch-ligand endocytosis by ligand-receptor interaction. | 3.82e-06 | 5 | 22 | 2 | 20720151 | |
| Interaction | MFAP5 interactions | 2.41e-05 | 52 | 22 | 3 | int:MFAP5 | |
| Interaction | IGFL3 interactions | 7.25e-05 | 75 | 22 | 3 | int:IGFL3 | |
| Cytoband | 14q11.2 | 3.35e-03 | 180 | 22 | 2 | 14q11.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr14q11 | 1.09e-02 | 332 | 22 | 2 | chr14q11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12p13 | 1.23e-02 | 353 | 22 | 2 | chr12p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q13 | 1.98e-02 | 454 | 22 | 2 | chr11q13 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 6.45e-05 | 13 | 17 | 2 | 685 | |
| GeneFamily | Ankyrin repeat domain containing | 1.40e-03 | 242 | 17 | 3 | 403 | |
| Coexpression | NABA_MATRISOME | 1.05e-06 | 1026 | 22 | 8 | M5889 | |
| Coexpression | NABA_MATRISOME | 1.25e-05 | 1008 | 22 | 7 | MM17056 | |
| Coexpression | BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS | 1.88e-05 | 8 | 22 | 2 | M9884 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.00e-05 | 196 | 22 | 4 | M3008 | |
| Coexpression | OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_DN | 4.42e-05 | 12 | 22 | 2 | M10336 | |
| Coexpression | NABA_CORE_MATRISOME | 7.47e-05 | 275 | 22 | 4 | M5884 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 8.01e-05 | 16 | 22 | 2 | M2207 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 8.01e-05 | 16 | 22 | 2 | MM1296 | |
| Coexpression | DESCARTES_FETAL_LIVER_MESOTHELIAL_CELLS | 1.23e-04 | 313 | 22 | 4 | M40228 | |
| Coexpression | LU_TUMOR_ANGIOGENESIS_UP | 1.99e-04 | 25 | 22 | 2 | M9946 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | 2.32e-04 | 1106 | 22 | 6 | M39071 | |
| Coexpression | WIKMAN_ASBESTOS_LUNG_CANCER_DN | 2.88e-04 | 30 | 22 | 2 | M9729 | |
| Coexpression | HALLMARK_NOTCH_SIGNALING | 3.29e-04 | 32 | 22 | 2 | M5903 | |
| Coexpression | ZHAN_LATE_DIFFERENTIATION_GENES_UP | 3.50e-04 | 33 | 22 | 2 | M10280 | |
| Coexpression | LI_CISPLATIN_RESISTANCE_DN | 3.50e-04 | 33 | 22 | 2 | M10150 | |
| Coexpression | GSE6269_E_COLI_VS_STREP_PNEUMO_INF_PBMC_DN | 3.64e-04 | 168 | 22 | 3 | M5662 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | 3.69e-04 | 767 | 22 | 5 | M39209 | |
| Coexpression | CUI_TCF21_TARGETS_2_UP | 4.39e-04 | 437 | 22 | 4 | M1610 | |
| Coexpression | CUI_TCF21_TARGETS_2_UP | 5.11e-04 | 455 | 22 | 4 | MM1189 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 5.15e-04 | 40 | 22 | 2 | M5887 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 5.30e-04 | 191 | 22 | 3 | MM17059 | |
| Coexpression | LTE2_UP.V1_DN | 5.63e-04 | 195 | 22 | 3 | M2721 | |
| Coexpression | HALLMARK_WNT_BETA_CATENIN_SIGNALING | 5.67e-04 | 42 | 22 | 2 | M5895 | |
| Coexpression | GSE23321_CENTRAL_MEMORY_VS_NAIVE_CD8_TCELL_DN | 5.80e-04 | 197 | 22 | 3 | M8431 | |
| Coexpression | GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN | 5.97e-04 | 199 | 22 | 3 | M6066 | |
| Coexpression | GSE3691_IFN_PRODUCING_KILLER_DC_VS_CONVENTIONAL_DC_SPLEEN_DN | 6.06e-04 | 200 | 22 | 3 | M6366 | |
| Coexpression | GSE6681_DELETED_FOXP3_VS_WT_TREG_DN | 6.06e-04 | 200 | 22 | 3 | M6779 | |
| Coexpression | GSE17721_LPS_VS_CPG_4H_BMDC_UP | 6.06e-04 | 200 | 22 | 3 | M3995 | |
| Coexpression | GSE37301_HEMATOPOIETIC_STEM_CELL_VS_COMMON_LYMPHOID_PROGENITOR_DN | 6.06e-04 | 200 | 22 | 3 | M8877 | |
| Coexpression | GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP | 6.06e-04 | 200 | 22 | 3 | M6537 | |
| Coexpression | HALLMARK_APICAL_SURFACE | 6.23e-04 | 44 | 22 | 2 | M5916 | |
| Coexpression | BROWNE_HCMV_INFECTION_48HR_DN | 6.35e-04 | 482 | 22 | 4 | M12144 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_NON_CLASSICAL_MONOCYTE_AGEING | 7.72e-04 | 49 | 22 | 2 | MM3772 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 3.81e-10 | 191 | 22 | 6 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 3.17e-08 | 190 | 22 | 5 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.25e-08 | 191 | 22 | 5 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.33e-08 | 192 | 22 | 5 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.42e-08 | 193 | 22 | 5 | 9f69edc97b868d23998abc98928a2e89a885ef8a | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.70e-08 | 196 | 22 | 5 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 3.89e-08 | 198 | 22 | 5 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.89e-08 | 198 | 22 | 5 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.89e-08 | 198 | 22 | 5 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.89e-08 | 198 | 22 | 5 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.89e-08 | 198 | 22 | 5 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 3.99e-08 | 199 | 22 | 5 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.99e-08 | 199 | 22 | 5 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.09e-08 | 200 | 22 | 5 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.09e-08 | 200 | 22 | 5 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.09e-08 | 200 | 22 | 5 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.09e-08 | 200 | 22 | 5 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.09e-08 | 200 | 22 | 5 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.94e-07 | 157 | 22 | 4 | f147e24f2ece82e1c54750868954d09b3c461804 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.02e-06 | 158 | 22 | 4 | e5636c0b608d68bd426a2b446ac508e4512e86a4 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.33e-06 | 169 | 22 | 4 | 031465190cd3623a25ef2b868daab8d932c8ff08 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-06 | 169 | 22 | 4 | a84490724a206c9bbb145f7ce08613f91d100ac4 | |
| ToppCell | COVID-19-kidney-REN+Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | 1.68e-06 | 179 | 22 | 4 | 342c1cc4444f51b8dcb30d3adc98285a25669c6e | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.75e-06 | 181 | 22 | 4 | a2058d658f07ab6f0a28d2622f3090b4cde6f763 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.75e-06 | 181 | 22 | 4 | 526e858a848470b6d2d5248788004d9735ed3add | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.75e-06 | 181 | 22 | 4 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.75e-06 | 181 | 22 | 4 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.91e-06 | 185 | 22 | 4 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.95e-06 | 186 | 22 | 4 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.99e-06 | 187 | 22 | 4 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 1.99e-06 | 187 | 22 | 4 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.99e-06 | 187 | 22 | 4 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.04e-06 | 188 | 22 | 4 | bba6b273bd47dd0e27fde914e9e6fc9d76fd5176 | |
| ToppCell | facs-Kidney-nan-3m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-06 | 189 | 22 | 4 | a5306561026e4dfcc39beeb785e5108ac595d136 | |
| ToppCell | facs-Kidney-nan-3m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-06 | 189 | 22 | 4 | 302b950a6ad578f8aeff7ea6fd15fe631225287d | |
| ToppCell | facs-Kidney-nan-3m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-06 | 189 | 22 | 4 | 381058f55908f84375b54601d617389ef43ab855 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.12e-06 | 190 | 22 | 4 | 0fea33f2dc1efa23aaa2da1c318482a52a313ff1 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-06 | 191 | 22 | 4 | 7b0d42a877540dbb346a76a62403e0d5d3e07fa6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-06 | 191 | 22 | 4 | cd854b9c426924fdc84bf7f411f6dea447143e79 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-06 | 192 | 22 | 4 | 41a8326cd5bc19ad5041068501bab4c72399222e | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-06 | 192 | 22 | 4 | f88aba74d6e8c594c32fe2bc095b5da28b4b28e9 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.21e-06 | 192 | 22 | 4 | 67e845e513e76e820f55e2f0d15eb16f2944d05c | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 2.26e-06 | 193 | 22 | 4 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.26e-06 | 193 | 22 | 4 | 7c0d84b92470bfda2db1e5007feee7c1235a0a78 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.26e-06 | 193 | 22 | 4 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.26e-06 | 193 | 22 | 4 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.26e-06 | 193 | 22 | 4 | 3d85c28f6ebdcb15e875ad01d52d6c138fbf8525 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.26e-06 | 193 | 22 | 4 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.31e-06 | 194 | 22 | 4 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.31e-06 | 194 | 22 | 4 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | Control-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 2.31e-06 | 194 | 22 | 4 | 3c2266772c5b56e8e02a461e5193e29588028ee9 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.31e-06 | 194 | 22 | 4 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 2.31e-06 | 194 | 22 | 4 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.31e-06 | 194 | 22 | 4 | 71d3c7448b1734de54187f902f65649f9283bd4c | |
| ToppCell | Control-Stromal-Myofibroblast|Control / Disease state, Lineage and Cell class | 2.35e-06 | 195 | 22 | 4 | ffcf76cd72e43d8cf1058a49c76e0956065038bc | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 2.35e-06 | 195 | 22 | 4 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.35e-06 | 195 | 22 | 4 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.40e-06 | 196 | 22 | 4 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.45e-06 | 197 | 22 | 4 | cfb3dc4b401800e33c82cfc3baee69dbbd16ac8c | |
| ToppCell | COVID-19_Severe|World / Disease group, lineage and cell class | 2.45e-06 | 197 | 22 | 4 | f0824f98269bdcd8463873beaf222df8f0caa468 | |
| ToppCell | PBMC-Severe|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.45e-06 | 197 | 22 | 4 | af10b5e6e959e2ced01ad066f906941bc4194cc3 | |
| ToppCell | PBMC-Severe|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.45e-06 | 197 | 22 | 4 | 3ff23b86d310ace388d2efb3ee73dd47c46f363e | |
| ToppCell | COVID-19-kidney-Fibroblast-2|kidney / Disease (COVID-19 only), tissue and cell type | 2.50e-06 | 198 | 22 | 4 | ca26ca460856b1faaa3e83766da6abdf63af2b51 | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 2.50e-06 | 198 | 22 | 4 | bd11b0e9e80449aab979a02c1023e0638c431c7c | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 2.50e-06 | 198 | 22 | 4 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.55e-06 | 199 | 22 | 4 | dfc5c7a4a093baa7158dd8d4d29a870d9c469a3f | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.55e-06 | 199 | 22 | 4 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.55e-06 | 199 | 22 | 4 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.55e-06 | 199 | 22 | 4 | c1760581c34b81d1d92c67500a1c8944e9cc6dad | |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | 2.55e-06 | 199 | 22 | 4 | 9503646ff1ad248181146ce767e9d12e882ec3bd | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.60e-06 | 200 | 22 | 4 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.60e-06 | 200 | 22 | 4 | 933b5b400e48a511ba0a056be1d33d3610b5f10d | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.60e-06 | 200 | 22 | 4 | ad3fdcef895400f929f2ae12ff9bd85fd46adb3a | |
| ToppCell | Skin-Fibroblasts|Skin / Skin and Kidney Cells in Lupus Nephritis Patients. | 2.60e-06 | 200 | 22 | 4 | f777eadf571a1a6d246da87346a9cb9d511c2e81 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.60e-06 | 200 | 22 | 4 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.60e-06 | 200 | 22 | 4 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Parenchymal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.60e-06 | 200 | 22 | 4 | 2e525c0d9684e7a2275edb04e1addb6fc6a872e5 | |
| ToppCell | COVID-19-COVID-19_Severe|COVID-19 / Disease, condition lineage and cell class | 2.60e-06 | 200 | 22 | 4 | 3ec89071f002bb66d46146bf4804f91e6f09a36f | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.60e-06 | 200 | 22 | 4 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.60e-06 | 200 | 22 | 4 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.60e-06 | 200 | 22 | 4 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.10e-05 | 125 | 22 | 3 | b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.99e-05 | 136 | 22 | 3 | 27a41463e6f16deb5b1d4f17fefded9959038c07 | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.99e-05 | 136 | 22 | 3 | 88b5c839d0446c6d6b7e81fc4d48f5e7e96eea11 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c07-AHNAK|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.03e-05 | 147 | 22 | 3 | 5e6dd2ddc67b3722f6528e7277cbc7f296098687 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum_-18m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.45e-05 | 151 | 22 | 3 | 3105b8c0c401faa92e1ab8223d435b21ed45c5b7 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.55e-05 | 152 | 22 | 3 | 621e9b33cd3bb1c7b7d0633069f286b203e3d9c0 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-neutrophil-neutrophil|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.66e-05 | 153 | 22 | 3 | ce6e462ce4dbaf9d265f1f9e2f791efbba8c1dd0 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-neutrophil|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.66e-05 | 153 | 22 | 3 | 9dba38574908f31a1194b8a339868f5e4be1be71 | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell-D122|Adult / Lineage, Cell type, age group and donor | 6.23e-05 | 158 | 22 | 3 | 410fa08c9d880d27e80ec939fa5ba5a41dcb31ab | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 6.47e-05 | 160 | 22 | 3 | fd14dfeb7021a4b7299371854dc8fc1fd66c8dae | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_D3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.59e-05 | 161 | 22 | 3 | 3e5a125a25d55bf27652f456239b00b315d54d91 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.71e-05 | 162 | 22 | 3 | 5f009b231f21861afee9cc0c569082e1135f929c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.71e-05 | 162 | 22 | 3 | b936f8040dcd4db621ccded19237af8df7d0ed6e | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.21e-05 | 166 | 22 | 3 | 94636dbc039f794c735960c3425e00bdd5523602 | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.21e-05 | 166 | 22 | 3 | 3037bdca38c3a65eacfa644219cc43c54e303749 | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.21e-05 | 166 | 22 | 3 | 5126d8f02314717eed341d867856fd4fe16c5118 | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell|Adult / Lineage, Cell type, age group and donor | 7.34e-05 | 167 | 22 | 3 | d584a8548a5317bd9686b3be8246ae6ed568796b | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.34e-05 | 167 | 22 | 3 | cb650f74306fa0d9f4bf49890b73065d193b94dc | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.48e-05 | 168 | 22 | 3 | d19a115365c5415e51c039718d7669de788fcf33 | |
| Drug | Epivincamine [6835-99-0]; Up 200; 11.2uM; HL60; HG-U133A | 9.98e-07 | 194 | 22 | 5 | 1783_UP | |
| Drug | bptc | 1.87e-05 | 7 | 22 | 2 | CID000167153 | |
| Drug | Oi-1 | 1.87e-05 | 7 | 22 | 2 | CID000448053 | |
| Drug | tripchlorolide | 3.20e-05 | 9 | 22 | 2 | CID000159588 | |
| Drug | Evoxine [522-11-2]; Up 200; 11.6uM; PC3; HT_HG-U133A | 3.52e-05 | 197 | 22 | 4 | 3681_UP | |
| Drug | 2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine | 3.99e-05 | 10 | 22 | 2 | ctd:C028145 | |
| Drug | AC1L9K10 | 5.85e-05 | 12 | 22 | 2 | CID000446726 | |
| Drug | butamben | 9.29e-05 | 15 | 22 | 2 | CID000002482 | |
| Drug | NSC523374 | 1.06e-04 | 16 | 22 | 2 | CID000101638 | |
| Drug | silver hydride | 1.68e-04 | 20 | 22 | 2 | CID000139654 | |
| Drug | O-11 | 2.64e-04 | 25 | 22 | 2 | CID000122098 | |
| Drug | MgSO4.7H2O | 2.64e-04 | 25 | 22 | 2 | CID000024843 | |
| Drug | AC1OCF9M | 3.56e-04 | 29 | 22 | 2 | CID006918304 | |
| Drug | Harmaline hydrochloride dihydrate [6027-98-1]; Up 200; 14uM; PC3; HT_HG-U133A | 8.20e-04 | 193 | 22 | 3 | 6623_UP | |
| Drug | Captopril [62571-86-2]; Up 200; 17.2uM; HL60; HG-U133A | 8.20e-04 | 193 | 22 | 3 | 1988_UP | |
| Drug | N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester | 8.23e-04 | 44 | 22 | 2 | ctd:C419410 | |
| Drug | Verteporfin [129497-78-5]; Up 200; 2.8uM; MCF7; HT_HG-U133A | 8.32e-04 | 194 | 22 | 3 | 3556_UP | |
| Drug | Asbestos, Serpentine | 8.37e-04 | 451 | 22 | 4 | ctd:D017632 | |
| Drug | genistein; Down 200; 1uM; MCF7; HG-U133A | 8.45e-04 | 195 | 22 | 3 | 268_DN | |
| Drug | Fursultiamine Hydrochloride [2105-43-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 8.45e-04 | 195 | 22 | 3 | 4975_DN | |
| Drug | Nizatidine [76963-41-2]; Up 200; 12uM; PC3; HT_HG-U133A | 8.58e-04 | 196 | 22 | 3 | 6305_UP | |
| Drug | fosmidomycin | 8.60e-04 | 45 | 22 | 2 | CID000000572 | |
| Drug | Tinidazole [19387-91-8]; Up 200; 16.2uM; PC3; HT_HG-U133A | 8.70e-04 | 197 | 22 | 3 | 3813_UP | |
| Drug | N6,2-O-dibutyryladenosine 3,5-cyclic monophosphate sodium salt; Up 200; 2uM; MCF7; HT_HG-U133A_EA | 8.70e-04 | 197 | 22 | 3 | 959_UP | |
| Drug | CP-690334-01 [459212-38-5]; Up 200; 1uM; MCF7; HT_HG-U133A | 8.83e-04 | 198 | 22 | 3 | 3909_UP | |
| Drug | gentamicin | 8.83e-04 | 198 | 22 | 3 | CID000003467 | |
| Drug | Betulinic acid [472-15-1]; Up 200; 8.8uM; PC3; HT_HG-U133A | 8.83e-04 | 198 | 22 | 3 | 4101_UP | |
| Drug | Reserpinic acid hydrochloride; Up 200; 9.2uM; PC3; HT_HG-U133A | 8.83e-04 | 198 | 22 | 3 | 6603_UP | |
| Drug | Sotalol hydrochloride [959-24-0]; Up 200; 13uM; PC3; HT_HG-U133A | 8.83e-04 | 198 | 22 | 3 | 4079_UP | |
| Drug | Tiapride hydrochloride [51012-33-0]; Up 200; 11uM; PC3; HT_HG-U133A | 8.83e-04 | 198 | 22 | 3 | 3663_UP | |
| Drug | TTNPB; Down 200; 0.1uM; PC3; HG-U133A | 8.96e-04 | 199 | 22 | 3 | 451_DN | |
| Drug | Terbutaline hemisulfate [23031-32-5]; Up 200; 7.2uM; MCF7; HT_HG-U133A | 8.96e-04 | 199 | 22 | 3 | 3202_UP | |
| Drug | Hyoscyamine (L) [101-31-5]; Up 200; 13.8uM; HL60; HG-U133A | 8.96e-04 | 199 | 22 | 3 | 1424_UP | |
| Drug | valinomycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 8.96e-04 | 199 | 22 | 3 | 5906_DN | |
| Drug | Cloxacillin sodium salt [642-78-4]; Up 200; 8.8uM; HL60; HG-U133A | 9.09e-04 | 200 | 22 | 3 | 1443_UP | |
| Disease | NKG2-D type II integral membrane protein measurement | 4.36e-06 | 5 | 20 | 2 | EFO_0008250 | |
| Disease | tyrosine-protein kinase receptor TYRO3 measurement | 1.22e-05 | 8 | 20 | 2 | EFO_0020829 | |
| Disease | tumor necrosis factor receptor superfamily member 19L measurement | 1.22e-05 | 8 | 20 | 2 | EFO_0008309 | |
| Disease | Antibody Deficiency Syndrome | 5.90e-05 | 17 | 20 | 2 | C0003257 | |
| Disease | tea consumption measurement | 8.81e-05 | 129 | 20 | 3 | EFO_0010091 | |
| Disease | Immunologic Deficiency Syndromes | 1.09e-04 | 23 | 20 | 2 | C0021051 | |
| Disease | congenital heart disease (is_implicated_in) | 1.19e-04 | 24 | 20 | 2 | DOID:1682 (is_implicated_in) | |
| Disease | Carcinoma, Pancreatic Ductal | 1.19e-04 | 24 | 20 | 2 | C0887833 | |
| Disease | Schizophrenia | 2.53e-04 | 883 | 20 | 5 | C0036341 | |
| Disease | myopathy (implicated_via_orthology) | 4.83e-04 | 48 | 20 | 2 | DOID:423 (implicated_via_orthology) | |
| Disease | pulmonary fibrosis (biomarker_via_orthology) | 5.24e-04 | 50 | 20 | 2 | DOID:3770 (biomarker_via_orthology) | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 5.89e-04 | 53 | 20 | 2 | C4707243 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WTEPPQCKDSTGKCG | 1096 | P08603 | |
| KTRCCCSKRPGEGWG | 2036 | Q75N90 | |
| KKWSPCSKPCGGGSQ | 861 | O95450 | |
| RWGPNCSLPCYCKNG | 576 | Q96KG7 | |
| KCRCPPGWSGKSCQQ | 126 | P46531 | |
| PPTKATCDQRGCCWN | 106 | O43451 | |
| PKCPTCGNFLGGKWI | 331 | Q12766 | |
| APGMWGPQCDKPCSC | 136 | Q5VY43 | |
| CGPCPKNWICYKNNC | 96 | P26718 | |
| WCQPGVTGKKCDRCA | 986 | P24043 | |
| CQNGTVCKPGWDGPK | 326 | Q13936 | |
| CPKPCDTGCTGWNKT | 506 | Q9HC77 | |
| FKCVCPPQWTGKTCQ | 396 | P78504 | |
| CPAGWTGDKCQSPCL | 1106 | O75095 | |
| CGKCKKNYQGRPWSP | 326 | Q9Y2I2 | |
| CQSDWQCPGKKRCCP | 51 | P03973 | |
| CDQKLGSGWQGPRPC | 466 | Q13796 | |
| CSCPSGWSGKRCNTP | 1506 | Q8N2E2 | |
| SGPCCSRCSQKKWPE | 291 | Q969Z4 | |
| FPCCRGSGKSKVGPW | 106 | Q6S5H5 | |
| FPCCRGSGKSKVGPW | 106 | A6NI47 | |
| CWACRQQKPCEPIGK | 396 | P51811 | |
| AGPCSPCWSCRGAKT | 1551 | Q13402 |